Σουηδία -
Σουηδικά -
Läkemedelsverket (Medical Products Agency)
quatrofen 100 mikrogram/timme depotplåster
takeda pharma ab - fentanyl - depotplåster - 100 mikrogram/timme - fentanyl 11 mg aktiv substans - fentanyl
Σουηδία -
Σουηδικά -
Läkemedelsverket (Medical Products Agency)
matrimed 12 mikrogram/timme depotplåster
takeda pharma ab - fentanyl - depotplåster - 12 mikrogram/timme - fentanyl 1,38 mg aktiv substans - fentanyl
Σουηδία -
Σουηδικά -
Läkemedelsverket (Medical Products Agency)
quatrofen 12 mikrogram/timme depotplåster
takeda pharma ab - fentanyl - depotplåster - 12 mikrogram/timme - fentanyl 1,38 mg aktiv substans - fentanyl
Σουηδία -
Σουηδικά -
Läkemedelsverket (Medical Products Agency)
matrimed 25 mikrogram/timme depotplåster
takeda pharma ab - fentanyl - depotplåster - 25 mikrogram/timme - fentanyl 2,75 mg aktiv substans - fentanyl
Σουηδία -
Σουηδικά -
Läkemedelsverket (Medical Products Agency)
quatrofen 25 mikrogram/timme depotplåster
takeda pharma ab - fentanyl - depotplåster - 25 mikrogram/timme - fentanyl 2,75 mg aktiv substans - fentanyl
Σουηδία -
Σουηδικά -
Läkemedelsverket (Medical Products Agency)
matrimed 50 mikrogram/timme depotplåster
takeda pharma ab - fentanyl - depotplåster - 50 mikrogram/timme - fentanyl 5,5 mg aktiv substans - fentanyl
Σουηδία -
Σουηδικά -
Läkemedelsverket (Medical Products Agency)
quatrofen 50 mikrogram/timme depotplåster
takeda pharma ab - fentanyl - depotplåster - 50 mikrogram/timme - fentanyl 5,5 mg aktiv substans - fentanyl
Σουηδία -
Σουηδικά -
Läkemedelsverket (Medical Products Agency)
matrimed 75 mikrogram/timme depotplåster
takeda pharma ab - fentanyl - depotplåster - 75 mikrogram/timme - fentanyl 8,25 mg aktiv substans - fentanyl
Σουηδία -
Σουηδικά -
Läkemedelsverket (Medical Products Agency)
quatrofen 75 mikrogram/timme depotplåster
takeda pharma ab - fentanyl - depotplåster - 75 mikrogram/timme - fentanyl 8,25 mg aktiv substans - fentanyl
Ευρωπαϊκή Ένωση -
Σουηδικά -
EMA (European Medicines Agency)
ceprotin
takeda manufacturing austria ag - humant protein c - purpura fulminans; protein c deficiency - antitrombotiska medel - ceprotin is indicated for prophylaxis and treatment of purpura fulminans coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.